Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313003039> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4313003039 abstract "<h3>Introduction/Background</h3> The prospective non-interventional study SCOUT-1 (NOGGO ov54; NCT04830709) investigates clinical real-world management of patients with advanced ovarian cancer in Germany with a special focus on quality of life (QoL) over a study period of seven years. <h3>Methodology</h3> All sites initiated through March 2022 were invited to document the cumulative number and characteristics of their OC patients treated in 2021. Details on site type and certification were also collected. The analysis has a descriptive and exploratory character. The variables are summarized using appropriate statistical methods. <h3>Results</h3> Until April 1st, 2022, 47 sites provided cumulative data: 36 (77%) full-service hospitals (university hospital, hospital with maximum or specialized care), 3 (6%) base service hospitals, and 8 (17%) office-based (gyneco)oncological sites. Majority of participating sites are certified (gyneco)oncological centres according the German Cancer Society. Each site treated on average 28 patients with 1L OC in 2021, with a large range of 4–127 patients (13% treated < 1 patient/month, 45% 1–2 patients/month and 43% >2 patients/month). The sites mainly diagnosed advanced stage FIGO III or IV disease (74%), serous histology (71%) and high-grade carcinoma (75%). Most patients received cytoreductive surgery. The majority of patients (80%) received and responded to platinum-based chemotherapy. <h3>Conclusion</h3> The analysis of cumulative data is in line with other epidemiologic sources in Germany and reflects a potential to enroll a representative cohort of patients with advanced OC in the SCOUT-1 study. Study is ongoing and is open for recruitment." @default.
- W4313003039 created "2023-01-05" @default.
- W4313003039 creator A5002555374 @default.
- W4313003039 creator A5010971321 @default.
- W4313003039 creator A5032677101 @default.
- W4313003039 creator A5050467390 @default.
- W4313003039 creator A5065512891 @default.
- W4313003039 creator A5068601323 @default.
- W4313003039 creator A5069247488 @default.
- W4313003039 date "2022-10-01" @default.
- W4313003039 modified "2023-10-14" @default.
- W4313003039 title "2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)" @default.
- W4313003039 doi "https://doi.org/10.1136/ijgc-2022-esgo.536" @default.
- W4313003039 hasPublicationYear "2022" @default.
- W4313003039 type Work @default.
- W4313003039 citedByCount "0" @default.
- W4313003039 crossrefType "proceedings-article" @default.
- W4313003039 hasAuthorship W4313003039A5002555374 @default.
- W4313003039 hasAuthorship W4313003039A5010971321 @default.
- W4313003039 hasAuthorship W4313003039A5032677101 @default.
- W4313003039 hasAuthorship W4313003039A5050467390 @default.
- W4313003039 hasAuthorship W4313003039A5065512891 @default.
- W4313003039 hasAuthorship W4313003039A5068601323 @default.
- W4313003039 hasAuthorship W4313003039A5069247488 @default.
- W4313003039 hasBestOaLocation W43130030391 @default.
- W4313003039 hasConcept C121608353 @default.
- W4313003039 hasConcept C126322002 @default.
- W4313003039 hasConcept C146357865 @default.
- W4313003039 hasConcept C151730666 @default.
- W4313003039 hasConcept C159110408 @default.
- W4313003039 hasConcept C17744445 @default.
- W4313003039 hasConcept C199539241 @default.
- W4313003039 hasConcept C2779951463 @default.
- W4313003039 hasConcept C46304622 @default.
- W4313003039 hasConcept C71924100 @default.
- W4313003039 hasConcept C72563966 @default.
- W4313003039 hasConcept C86803240 @default.
- W4313003039 hasConceptScore W4313003039C121608353 @default.
- W4313003039 hasConceptScore W4313003039C126322002 @default.
- W4313003039 hasConceptScore W4313003039C146357865 @default.
- W4313003039 hasConceptScore W4313003039C151730666 @default.
- W4313003039 hasConceptScore W4313003039C159110408 @default.
- W4313003039 hasConceptScore W4313003039C17744445 @default.
- W4313003039 hasConceptScore W4313003039C199539241 @default.
- W4313003039 hasConceptScore W4313003039C2779951463 @default.
- W4313003039 hasConceptScore W4313003039C46304622 @default.
- W4313003039 hasConceptScore W4313003039C71924100 @default.
- W4313003039 hasConceptScore W4313003039C72563966 @default.
- W4313003039 hasConceptScore W4313003039C86803240 @default.
- W4313003039 hasLocation W43130030391 @default.
- W4313003039 hasOpenAccess W4313003039 @default.
- W4313003039 hasPrimaryLocation W43130030391 @default.
- W4313003039 hasRelatedWork W1989579502 @default.
- W4313003039 hasRelatedWork W2071535500 @default.
- W4313003039 hasRelatedWork W2315085516 @default.
- W4313003039 hasRelatedWork W2316407790 @default.
- W4313003039 hasRelatedWork W2356105190 @default.
- W4313003039 hasRelatedWork W2383775094 @default.
- W4313003039 hasRelatedWork W2603773853 @default.
- W4313003039 hasRelatedWork W2752094163 @default.
- W4313003039 hasRelatedWork W2952239533 @default.
- W4313003039 hasRelatedWork W2994700791 @default.
- W4313003039 isParatext "false" @default.
- W4313003039 isRetracted "false" @default.
- W4313003039 workType "article" @default.